![Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison - Seizure - European Journal of Epilepsy Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison - Seizure - European Journal of Epilepsy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/ab23d054-34cb-4fe0-b475-f48f00020ea0/gr1.jpg)
Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison - Seizure - European Journal of Epilepsy
![Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis - Seizure - European Journal of Epilepsy Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis - Seizure - European Journal of Epilepsy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7cfac8a0-5f68-4500-9515-f7ce977203f3/gr1_lrg.jpg)
Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis - Seizure - European Journal of Epilepsy
![DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research - Epilepsy & Behavior DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research - Epilepsy & Behavior](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b1bfba51-d12b-4a28-b898-31053f3e522d/ga1_lrg.jpg)
DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research - Epilepsy & Behavior
![Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials - Li - 2021 - Epilepsia - Wiley Online Library Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials - Li - 2021 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/460f8165-3d47-4aab-af81-f974e699c18e/epi17015-fig-0005-m.jpg)
Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials - Li - 2021 - Epilepsia - Wiley Online Library
![Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial - The Lancet Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e5c867ee-87af-4605-bdc5-fa48227e7a56/gr1_lrg.gif)
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial - The Lancet
![Fenfluramine Consistently Reduces Seizures in Children and Young Adults with Dravet Syndrome - Practical Neurology Fenfluramine Consistently Reduces Seizures in Children and Young Adults with Dravet Syndrome - Practical Neurology](https://core4.bmctoday.net/storage/images/091020_FenfluramineTable_1599767573.jpg)
Fenfluramine Consistently Reduces Seizures in Children and Young Adults with Dravet Syndrome - Practical Neurology
![Frontiers | Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations Frontiers | Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations](https://www.frontiersin.org/files/Articles/285292/fneur-08-00505-HTML/image_m/fneur-08-00505-g001.jpg)
Frontiers | Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations
![National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management - European Medical Journal National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/06/Figures-Tables-5.2-Articles4.jpg)
National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management - European Medical Journal
![Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119123200/2089445089/gr1.gif)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet
![The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis - Epilepsy & Behavior The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis - Epilepsy & Behavior](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/15af2d03-5f17-40ba-ba13-255d96bfc52e/gr1_lrg.jpg)